Tacrolimus inhibits calcineurin, a protein phosphatase involved in the activation of T-cells, which are part of the immune system. By doing so, it reduces the production of interleukin-2, a cytokine that promotes the growth and activity of T-cells. This mechanism helps prevent the immune system from attacking the transplanted organ.
